TrialVaccine2022

Neutralizing antibody correlates of sequence specific dengue disease in a tetravalent dengue vaccine efficacy trial in Asia.

Li Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.